Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes-Reference-Cited by-同舟云学术

Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes

Published:2020-04-01 Issue:4 Volume:22 Page:278-284
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Kapitza Christoph¹,Nosek Leszek¹,Schmider Wolfgang²,Teichert Lenore²,Nowotny Irene²

Affiliation:

1. Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany.

2. Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2019.0351

Reference14 articles.

1. Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience

2. Insulin Access and Affordability Working Group: Conclusions and Recommendations

3. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?

5. Euglycaemic glucose clamp: what it can and cannot do, and how to do it

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial;Journal of Diabetes Science and Technology;2024-02-29

2. Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial;Diabetes, Obesity and Metabolism;2023-10-25

3. How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers;Frontiers in Pharmacology;2022-07-22

5. Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects;Scientific Reports;2021-11-25